CEL-SCI Corporation Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CEL-SCI Corporation (CEL-SCI) on August 27, 2025, with the earliest event reported on that date. The filing details the entry into a Material Definitive Agreement regarding a private placement of common stock.
Key Financial Metrics and Transaction Details
- Transaction Type: Private placement of common stock.
- Shares Issued: 1,111,200 shares.
- Offering Price: $9.00 per share.
- Gross Proceeds: Approximately $10,000,800.
- Placement Agent Fees: 7.0% of gross proceeds plus expense reimbursement up to $185,000.
- Use of Proceeds: Funding continued development of Multikine, general corporate purposes, and working capital.
- Closing Date: August 29, 2025.
Note: This filing does not provide revenue, profit, cash flow, margin, or debt metrics for the company's ongoing operations.
Material Changes and Agreements
The primary material change is the capital raise described above. Key contractual terms include:
- Company Lock-Up: CEL-SCI agreed not to issue or announce the issuance of common stock or convertible securities for 30 days following the closing.
- Insider Lock-Up: Directors and officers agreed to a 45-day lock-up period on their existing holdings.
- Registration: Securities were sold pursuant to an effective Form S-3 registration statement declared effective on August 12, 2025.
Outlook, Risks, and Management Commentary
Management intends to utilize the net proceeds to advance the development of Multikine. The filing includes standard forward-looking statement disclaimers, noting that actual results may differ materially from projections. Investors are directed to the "Risk Factors" section in the prospectus supplement filed on August 27, 2025, and the Annual Report on Form 10-K for the fiscal year ended September 30, 2024, for detailed risk information.
Key Facts for Investor Verification
- Verify the exact net proceeds after deducting the 7% placement fee and up to $185,000 in expenses.
- Confirm the specific milestones for the Multikine development program funded by this capital.
- Review the full text of the Placement Agency Agreement (Exhibit 1.1) for additional covenants or termination provisions.
- Check the company's current cash position and burn rate in the most recent 10-K or 10-Q to assess the runway provided by this $10 million raise.
- Monitor compliance with the 30-day and 45-day lock-up periods for the company and insiders, respectively.